Head-to-head · Cost-Efficiency Index
CoreAge Rx vs Medical Health Institute
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
CoreAge Rx
Anyone optimizing for real value — a transparent flat price you can model for a full year, nationwide, without a bait-and-switch.
Visit CoreAge RxMedical Health Institute
Shoppers comparing across TRT, peptides, and weight loss under one provider who don't need public pricing detail up front.
Visit Medical Health InstituteThe verdict
CoreAge Rx takes it, leading the Cost-Efficiency Index 94 to 68. Best value in the ranking: both molecules at one flat, all-50 price with no teaser step-ups — the lowest true cost of ownership, not the lowest teaser. Medical Health Institute still earns a C — Shoppers comparing across TRT, peptides, and weight loss under one provider who don't need public pricing detail up front.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | CoreAge Rx | Medical Health Institute |
|---|---|---|
| Cost-Efficiency Index | 94/100 | 68/100 |
| Semaglutide / mo | $99/mo | $100/mo (all doses, compounded) |
| Tirzepatide / mo | $149/mo | Not disclosed |
| Semaglutide / yr (modeled) | $1,188 | $1,200 |
| Tirzepatide / yr (modeled) | $1,788 | — |
| Coverage | All 50 states | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #1 | #125 |
CoreAge Rx
94/100Where the value is
- Flat all-in monthly price — no intro rate that silently triples after month one, so the modeled annual cost is the real cost
- Both compounded semaglutide and tirzepatide on one account at published prices
- Available in all 50 states — no coverage gamble
The tradeoffs
- Not the rock-bottom sticker price — 30 of the 381 priced semaglutide programs we track list a cheaper figure, though most attach a term or a step-up that CoreAge does not
- No FDA-approved brand-name option (compounded only)
Medical Health Institute
68/100Where the value is
- Advertises a competitively low $100/mo entry price for GLP-1 weight loss
- Offers multiple service lines (weight loss, TRT, peptide therapy) under one provider
- LegitScript and HIPAA-compliance badges both displayed on the homepage
The tradeoffs
- The $100/mo headline price carries the company's own asterisk — '*Based on pharmacy availability' — meaning it is explicitly not a guaranteed rate before intake
- No dose tier or even which drug (semaglutide vs. tirzepatide) the $100 figure applies to is disclosed anywhere public
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.